Elaeagnus angustifolia Plant Extract Inhibits Angiogenesis and Downgrades Cell Invasion of Human Oral Cancer Cells via Erk1/Erk2 Inactivation

References

• Farzaei MH, Bahramsoltani R, Abbasabadi Z, Rahimi R: A comprehensive review on phytochemical and pharmacological aspects of Elaeagnus angustifolia L. J Pharm Pharmacol 67, 1467–1480, 2015.
   PubMed Web of Science ®Google Scholar
• Klich MG: Leaf variations in Elaeagnus angustifolia related to environmental heterogeneity. Environ Exp Bot 44, 171–183, 2000.
   PubMed Web of Science ®Google Scholar
• Saboonchian F, Jamei R, Hosseini Sarghein S: Phenolic and flavonoid content of Elaeagnus angustifolia L. (leaf and flower). Avicenna J Phytomed 4, 231–238, 2014.
   PubMedGoogle Scholar
• Farzaei MH, Bahramsoltani R, Abbasabadi Z, Rahimi R: A comprehensive review on phytochemical and pharmacological aspects of Elaeagnus angustifolia L. J Pharm Pharmacol 67, 1467–1480, 2015
   PubMed Web of Science ®Google Scholar
• Niknam F, Azadi A, Barzegar A, Faridi P, Tanideh N, et al.: Phytochemistry and phytotherapeutic aspects of Elaeagnus angustifolia L. Curr Drug Discov Technol 13, 199–210, 2016.
   PubMedGoogle Scholar
• Torbati M, Asnaashari S, Heshmati Afshar F: 2016. Essential oil from flowers and leaves of Elaeagnus angustifolia (Elaeagnaceae): Composition, radical scavenging and general toxicity activities. Adv Pharm Bull 6, 163–169, 2016.
   PubMed Web of Science ®Google Scholar
• Nikniaz Z, Ostadrahimi A, Mahdavi R, Ebrahimi AA, Nikniaz L: Effects of Elaeagnus angustifolia L. supplementation on serum levels of inflammatory cytokines and matrix metalloproteinases in females with knee osteoarthritis. Complement Ther Med 22, 864–869, 2014.
   PubMed Web of Science ®Google Scholar
• Beigom Taheri J, Anbari F, Maleki Z, Boostani S, Zarghi A, et al.: Efficacy of Elaeagnus angustifolia topical gel in the treatment of symptomatic oral lichen planus. J Dent Res Dent Clin Dent Prospects 4, 29–32, 2010.
   PubMedGoogle Scholar
• Panahi Y, Alishiri GH, Bayat N, Hosseini SM, Sahebkar A: Efficacy of Elaeagnus angustifolia extract in the treatment of knee osteoarthritis: a randomized controlled trial. EXCLI J 15, 203–210, 2016.
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R, Ramadas K, Amarasinghe H, Subramanian S, Johnson N: Oral cancer: prevention, early detection, and treatment. In: Cancer: Disease Control Priorities, Third Edition ( Volume 3), Gelband H, Jha P, Sankaranarayanan R, Horton S ( eds). Washington, DC: The International Bank for Reconstruction and Development / The World Bank; Chapter 5, 2015.
   Google Scholar
• Bagan J, Sarrion G, Jimenez Y: Oral cancer: clinical features. Oral Oncol 46, 414–417, 2010.
   PubMed Web of Science ®Google Scholar
• Noguti J, De Moura CF, De Jesus GP, Da Silva VH, Hossaka TA, et al.: Metastasis from oral cancer: an overview. Cancer Genomics Proteomics 9, 329–335, 2012.
   PubMed Web of Science ®Google Scholar
• Ala-Eddin Al Moustafa, and Amber Yasmeen: E-cadherin/catenin complex modulations in human oral cancer, intercellular communication in cancer. In: Intercellular communication in cancer, Prof. Mustapha Kandouz (ed.). Germany: Springer, 2015.
   Google Scholar
• Okura M, Aikawa T, Sawai NY, Iida S, Kogo M: Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol 45, 908–911, 2009.
   PubMed Web of Science ®Google Scholar
• Al Moustafa AE, Achkhar A, Yasmeen A: EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas. Front Biosci (Schol Ed.) 4, 671–684, 2012.
   PubMedGoogle Scholar
• Marla V, Hegde V, Shrestha A: Relationship of angiogenesis and oral squamous cell carcinoma. Kathmandu Univ Med J (KUMJ) 13, 178–85, 2015.
   PubMedGoogle Scholar
• Roman D, Yasmeen A, Mireuta M, Stiharu I, Al Moustafa AE: Significant toxic role for single-walled carbon nanotubes during normal embryogenesis. Nanomedicine 9, 945–950, 2013.
   PubMed Web of Science ®Google Scholar
• Zudaire E, Gambardella L, Kurcz C, Vermeren S: A computational tool for quantitative analysis of vascular networks. PLoS One 6, e27385, 2011.
   PubMed Web of Science ®Google Scholar
• Yasmeen A, Alachkar A, Dekhil H, Gambacorti-Passerini C, Al Moustafa AE: Locking Src/Abl tyrosine kinase activities regulate cell differentiation and invasion of human cervical cancer cells expressing E6/E7 oncoproteins of high-risk HPV. J Oncol 2010, pii 530130, 2010.
   Google Scholar
• Zhang L, Chen W, Li X: A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-kappa B signaling pathways in bladder cancer cells. FEBS Lett 582, 1821–1828, 2008.
   PubMed Web of Science ®Google Scholar
• Weiss MB, Abel EV, Mayberry MM, Basile KJ, Berger AC, et al.: WIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells. Cancer Res 72, 6382–6392, 2012.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin Z, Sun L, Fan S, Huang Z, et al.: Akt/Ezrin Tyr353/NF-κB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma. Br J Cancer 110, 695–705, 2014.
   PubMed Web of Science ®Google Scholar
• Zhang XJ and Jia SS: Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways. Biomed Pharmacother 83, 1164–1174, 2016.
   PubMed Web of Science ®Google Scholar
• Yasmeen A, Bismar TA, Al Moustafa AE: ErbB receptors and epithelial-cadherin-catenin complex in human carcinomas. Future Oncol 2, 765–781, 2006
   PubMedGoogle Scholar
• Maggioni D, Biffi L, Nicolini G, Garavello W: Flavonoids in oral cancer prevention and therapy. Eur J Cancer Prev 24, 517–528, 2015.
   PubMed Web of Science ®Google Scholar
• Pudenz M, Roth K, Gerhauser C: Impact of soy isoflavones on the epigenome in cancer prevention. Nutrients 6, 4218–4272, 2014.
   PubMed Web of Science ®Google Scholar
• Moreno-Bueno G, Portillo F, Cano A: Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 27, 6958–6969, 2008.
   PubMed Web of Science ®Google Scholar
• Gong W, Xiao Y, Wei Z, Yuan Y, Qiu M, et al.: Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma. Oncotarget 8(2), 2141–2152, 2017.
   PubMed Web of Science ®Google Scholar
• Saba-El-Leil MK, Frémin C, Meloche S: Redundancy in the world of MAP kinases: all for one. Front Cell Dev Biol 4, 67, 2016.
   PubMed Web of Science ®Google Scholar
• Torres AF, Nogueira C, Magalhaes J, Costa IS, Aragao A, et al.: Expression of EGFR and molecules downstream to PI3K/Akt, Raf-1-MEK-1-MAP (Erk1/2), and JAK (STAT3) pathways in invasive lung adenocarcinomas resected at a single institution. Anal Cell Pathol (Amst) 2014, 352925, 2014.
   PubMedGoogle Scholar
• Starska K, Forma E, Jóźwiak P, Lewy-Trenda I, Danilewicz M, et al.: Gene/protein expression of CAPN1/2-CAST system members is associated with ERK1/2 kinases activity as well as progression and clinical outcome in human laryngeal cancer. Tumour Biol 37, 13185–13203, 2016.
   PubMedGoogle Scholar
• Kandouz M, Alachkar A, Zhang L, Dekhil H, Chehna F, et al.: Teucrium polium plant extract inhibits cell invasion and motility of human prostate cancer cells via the restoration of the E-cadherin/catenin complex. J Ethnopharmacol 129, 410–415, 2010.
   PubMed Web of Science ®Google Scholar
• Koirala N, Thuan NH, Ghimire GP, Thang DV, Sohng JK: Methylation of flavonoids: chemical structures, bioactivities, progress and perspectives for biotechnological production. Enzyme Microb Technol 86, 103–116, 2016.
   PubMed Web of Science ®Google Scholar